Dynamic Contrast-Enhanced Computed Tomography Imaging Biomarkers Correlated With Immunohistochemistry for Monitoring the Effects of Sorafenib on Experimental Prostate Carcinomas

Assessment of Acute Antivascular Effects of Vandetanib with High-Resolution Dynamic Contrast-Enhanced Computed Tomographic Imaging in a Human Colon Tumor Xenograft Model in the Nude Rat

(2015) Joo Ho Tai et al.   NEOPLASIA

On the scope and interpretation of the Tofts models for DCE-MRI

(2011) Steven P. Sourbron et al.   MAGNETIC RESONANCE IN MEDICINE

Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies

(2010) E. L. Mayer et al.   CLINICAL CANCER RESEARCH

Dynamic contrast-enhanced computed tomography for the quantification of tumor response to vasoactive agents in a rat tumor model: preliminary results

(2010) Rachel E. Pollard et al.   Contrast Media & Molecular Imaging

Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer

(2010) Elaine T. Lam et al.   JOURNAL OF CLINICAL ONCOLOGY

Benign prostatic hyperplasia: Evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI

(2010) Lucy E. Kershaw et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

CT perfusion in oncology: how to do it

(2010) G. Petralia et al.   CANCER IMAGING

Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer

(2009) Giulia Bianchi et al.   ANTI-CANCER DRUGS

Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer

(2009) Jeanny B. Aragon-Ching et al.   BJU INTERNATIONAL

In Vivo Monitoring of Angiogenesis Inhibitory Treatment Effects by Dynamic Contrast-Enhanced Computed Tomography in a Xenograft Tumor Model

(2009) Hans-Juergen Raatschen et al.   INVESTIGATIVE RADIOLOGY

Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI

(2009) Steven Sourbron et al.   MAGNETIC RESONANCE IN MEDICINE

Sorafenib Triggers Antiproliferative and Pro-Apoptotic Signals in Human Esophageal Adenocarcinoma Cells

(2008) Jorge-Shmuel Delgado et al.   DIGESTIVE DISEASES AND SCIENCES

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Experimental therapy for advanced renal cell carcinoma

(2008) Thomas E Hutson et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung Cancer

(2008) Simon J. Crabb et al.   JOURNAL OF CLINICAL ONCOLOGY

New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues

(2008) Clemens C. Cyran et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Multimodality Molecular Imaging of Tumor Angiogenesis

(2008) W. Cai et al.   JOURNAL OF NUCLEAR MEDICINE

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

(2008) Scott M. Wilhelm et al.   MOLECULAR CANCER THERAPEUTICS

MRI-Measurement of Perfusion and Glomerular Filtration in the Human Kidney With a Separable Compartment Model

(2007) Steven P. Sourbron et al.   INVESTIGATIVE RADIOLOGY